179 related articles for article (PubMed ID: 32580723)
1. Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas.
Wang C; Liu S; Peng L; Zhang K; Li W; Zhang H; Luan Y; Li P; Hu X
BMC Cancer; 2020 Jun; 20(1):591. PubMed ID: 32580723
[TBL] [Abstract][Full Text] [Related]
2. Low-dose rate stereotactic iodine-125 brachytherapy for the treatment of inoperable primary and recurrent glioblastoma: single-center experience with 201 cases.
Kickingereder P; Hamisch C; Suchorska B; Galldiks N; Visser-Vandewalle V; Goldbrunner R; Kocher M; Treuer H; Voges J; Ruge MI
J Neurooncol; 2014 Dec; 120(3):615-23. PubMed ID: 25151509
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas.
Cuneo KC; Vredenburgh JJ; Sampson JH; Reardon DA; Desjardins A; Peters KB; Friedman HS; Willett CG; Kirkpatrick JP
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2018-24. PubMed ID: 21489708
[TBL] [Abstract][Full Text] [Related]
4. Interstitial brachytherapy versus cytoreductive surgery in recurrent malignant glioma.
Ryken TC; Hitchon PW; VanGilder JC; Wen BC; Jani S
Stereotact Funct Neurosurg; 1994; 63(1-4):241-5. PubMed ID: 7624640
[TBL] [Abstract][Full Text] [Related]
5. Permanent iodine 125 brachytherapy in patients with progressive or recurrent glioblastoma multiforme.
Larson DA; Suplica JM; Chang SM; Lamborn KR; McDermott MW; Sneed PK; Prados MD; Wara WM; Nicholas MK; Berger MS
Neuro Oncol; 2004 Apr; 6(2):119-26. PubMed ID: 15134626
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic iodine-125 brachytherapy for the treatment of WHO grades II and III gliomas located in the central sulcus region.
Ruge MI; Kickingereder P; Grau S; Dorn F; Galldiks N; Treuer H; Sturm V
Neuro Oncol; 2013 Dec; 15(12):1721-31. PubMed ID: 24046261
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic brachytherapy of low-grade cerebral glioma after tumor resection.
Suchorska B; Ruge M; Treuer H; Sturm V; Voges J
Neuro Oncol; 2011 Oct; 13(10):1133-42. PubMed ID: 21868412
[TBL] [Abstract][Full Text] [Related]
8. Resection and brain brachytherapy with permanent iodine-125 sources for brain metastasis.
Raleigh DR; Seymour ZA; Tomlin B; Theodosopoulos PV; Berger MS; Aghi MK; Geneser SE; Krishnamurthy D; Fogh SE; Sneed PK; McDermott MW
J Neurosurg; 2017 Jun; 126(6):1749-1755. PubMed ID: 27367240
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcome of stereotactic brachytherapy with temporary Iodine-125 seeds in patients with WHO grade II gliomas.
Watson J; Romagna A; Ballhausen H; Niyazi M; Lietke S; Siller S; Belka C; Thon N; Nachbichler SB
Radiat Oncol; 2020 Dec; 15(1):275. PubMed ID: 33298103
[TBL] [Abstract][Full Text] [Related]
10. Permanent iodine-125 interstitial implants for the treatment of recurrent glioblastoma multiforme.
Patel S; Breneman JC; Warnick RE; Albright RE; Tobler WD; van Loveren HR; Tew JM
Neurosurgery; 2000 May; 46(5):1123-8; discussion 1128-30. PubMed ID: 10807244
[TBL] [Abstract][Full Text] [Related]
11. Reirradiation in progressive high-grade gliomas: outcome, role of concurrent chemotherapy, prognostic factors and validation of a new prognostic score with an independent patient cohort.
Scholtyssek F; Zwiener I; Schlamann A; Seidel C; Meixensberger J; Bauer M; Hoffmann KT; Combs SE; von Bueren AO; Kortmann RD; Müller K
Radiat Oncol; 2013 Jul; 8():161. PubMed ID: 23822643
[TBL] [Abstract][Full Text] [Related]
12. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
[TBL] [Abstract][Full Text] [Related]
13. Outcome and toxicity profile of salvage low-dose-rate iodine-125 stereotactic brachytherapy in recurrent high-grade gliomas.
Schwartz C; Romagna A; Thon N; Niyazi M; Watson J; Belka C; Tonn JC; Kreth FW; Nachbichler SB
Acta Neurochir (Wien); 2015 Oct; 157(10):1757-64; discussion 1764. PubMed ID: 26298594
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous computed tomography/ultrasonography-guided permanent iodine-125 implantation as salvage therapy for recurrent squamous cell cancers of head and neck.
Jiang YL; Meng N; Wang JJ; Ran WQ; Yuan HS; Qu A; Yang RJ
Cancer Biol Ther; 2010 Jun; 9(12):959-66. PubMed ID: 20873398
[TBL] [Abstract][Full Text] [Related]
15. Management and survival rates in patients with glioma in China (2004-2010): a retrospective study from a single-institution.
Yang P; Wang Y; Peng X; You G; Zhang W; Yan W; Bao Z; Wang Y; Qiu X; Jiang T
J Neurooncol; 2013 Jun; 113(2):259-66. PubMed ID: 23483435
[TBL] [Abstract][Full Text] [Related]
16. Salvage low-dose-rate permanent seed brachytherapy for locally recurrent prostate cancer: Association between dose and late toxicity.
Rose JN; Crook JM; Pickles T; Keyes M; Morris WJ
Brachytherapy; 2015; 14(3):342-9. PubMed ID: 25727178
[TBL] [Abstract][Full Text] [Related]
17. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic brachytherapy with iodine-125 seeds for the treatment of inoperable low-grade gliomas in children: long-term outcome.
Ruge MI; Simon T; Suchorska B; Lehrke R; Hamisch C; Koerber F; Maarouf M; Treuer H; Berthold F; Sturm V; Voges J
J Clin Oncol; 2011 Nov; 29(31):4151-9. PubMed ID: 21969508
[TBL] [Abstract][Full Text] [Related]
19. Recurrent malignant gliomas: survival following interstitial brachytherapy with high-activity iodine-125 sources.
Gutin PH; Leibel SA; Wara WM; Choucair A; Levin VA; Philips TL; Silver P; Da Silva V; Edwards MS; Davis RL
J Neurosurg; 1987 Dec; 67(6):864-73. PubMed ID: 3316532
[TBL] [Abstract][Full Text] [Related]
20. Changes in presentation, treatment, and outcomes of adult low-grade gliomas over the past fifty years.
Youland RS; Schomas DA; Brown PD; Nwachukwu C; Buckner JC; Giannini C; Parney IF; Laack NN
Neuro Oncol; 2013 Aug; 15(8):1102-10. PubMed ID: 23814262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
